Stay updated with breaking news from Gerald Mossinghoff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
Since pharmaceutical companies started funding their FDA drug applications 30 years ago, the agency’s reviews have gone much faster — perhaps too fast.
The pharma-funded system at the FDA is becoming more prevalent and, because of the funding structure now in place, will not be easy to unpick. With such a large proportion of the drug regulation budget deriving directly from drug makers, and more input from drug makers at every stage in the process, the divide between the FDA and drug makers is rapidly shrinking.
Since pharmaceutical companies started funding their FDA drug applications, the agency’s reviews have gone much faster — perhaps too fast.